Results 241 to 250 of about 545,708 (260)

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-Vornhagen, Boris Böll, Peter Schellongowski   +2 more
exaly  

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023
Rujul Parikh, Sagar Lonial
exaly  

Toll/Interleukin-1 Receptor-Like Protein 3

2018
openaire   +1 more source

IL-33, an Interleukin-1-like Cytokine that Signals via the IL-1 Receptor-Related Protein ST2 and Induces T Helper Type 2-Associated Cytokines

Immunity, 2005
Xiaoxia Li, J Fernando Bazan
exaly  

Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease

Lancet, The, 2005
David A Van Heel, Subrata Ghosh, Raymond John Playford   +2 more
exaly  

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial

Lancet, The, 2008
Andrea Rubbert-Roth, César R Ramos-Remus, Rieke E Alten   +2 more
exaly  

Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist

Lancet, The, 2004
Hal M Hoffman
exaly  

Molecular cloning and expression of cDNAs for the human interleukin-2 receptor

Nature, 1984
Warren J Leonard
exaly  

Interleukin-1 receptor antagonist and interleukin-6 for early diagnosis of neonatal sepsis 2 days before clinical manifestation

Lancet, The, 1998
Irmela Jeremias
exaly  

Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies

Lancet, The, 2012
Daniel F Freitag, John Gregson, Peter Willeit   +2 more
exaly